
Maxim Sevostyanov
Director of Global Regulatory and Medical Translations
Education:
2015—2019 — Manash Kozybayev
North Kazakhstan University

gaukhar bilimbayeva
Chief Executive Officer (CEO), PharmD, MBA
Education:
1997—2002 — S. Asfendiyarov Kazakh National Medical University
2016—2018 — MBA, Swiss Business School, Zurich, Switzerland

dauren bilimbayev
Founder
Education:
2000—2004 — T. Ryskulov Kazakh Economic University
2003—2005 — S. Amanzholov East Kazakhstan State University
2016—2017 — NIMA International Marketing School, the Netherlands

Anna polivoda
Deputy CEO, Head
of Sales and Marketing
Education:
2018—2022 — Almaty Management University (AlmaU)
2022—2024 — Sh. Murtaza International University

gulzhan akhmetova
Head of Registration Department,
Quality Responsible Person
Education:
2005—2009 — Al-Farabi Kazakh National University
2013—2015 — K. I. Satpayev Kazakh National Technical University (KazNTU)

Bulegenova Zhadyra
Senior Registration Specialist
Education:
2008-2012 — Al-Farabi Kazakh National University (Bachelor's)
2012-2014 — S. Asfendiyarov Kazakh National Medical University (Master's)

Jenis Kamila
Registration Specialist
Education:
2016-2020 — S. Asfendiyarov Kazakh National Medical University

Asel Seidakhmetova
Senior Registration Specialist
Education:
2006-2010 — Kazakh National Agrarian University (KazNAU)





















Preparation of the dossier, reference standards and samples takes from 1 to 12 months. This is followed by up to 14 days for submission and up to 180 calendar days for examination and registration.
The product is included in the State Register of Medicines and Medical Products, and a Certificate of State Registration valid for 5 years is issued, granting the right to import and market the product in Turkmenistan.
The documents, reference standards and samples are submitted to the State Center for Registration of Medicines of the Ministry of Health and Medical Industry of Turkmenistan. Issues of safety, quality and efficacy are reviewed by the Pharmacological and Pharmacopoeial Committees.
The dossier documents are translated into Russian, and the instructions for use into Turkmen, Russian and/or English. The instructions for use are also developed, and the application for state registration is prepared.
Laboratory verification of the reproducibility of the submitted quality control methods is carried out on samples of the product. To reduce the risk of non-reproducibility, the methods are checked in advance, and samples and working standards are supplied in sufficient quantities.